Prime Medicine, Inc.
PRME
$3.68
$0.010.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.00% | 3.69% | 4.95% | -13.39% | 35.60% |
| Total Depreciation and Amortization | 9.26% | 20.73% | 21.20% | 29.28% | 37.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.10% | 63.74% | -32.80% | 31.18% | 30.61% |
| Change in Net Operating Assets | -97.63% | -96.43% | 111.54% | 74.58% | 238.13% |
| Cash from Operations | -329.34% | -35.22% | 8.97% | 27.84% | 137.03% |
| Capital Expenditure | 83.81% | 80.66% | 17.35% | -4.22% | 2.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.81% | -277.99% | -50.63% | -30.58% | 16.04% |
| Cash from Investing | -41.29% | -282.99% | -59.81% | -28.92% | 16.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56,100.00% | 260.28% | 462.86% | -- | -99.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -75.81% | -- |
| Cash from Financing | 56,100.00% | 275.85% | 462.86% | -96.19% | -99.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.97% | -72.05% | 0.31% | -272.28% | 2,804.36% |